Recognition
Institutional trust, worldwide
World Health Innovation Summit leadership has advised global institutions and co-founded the Global Social Prescribing Alliance (GSPA), which the UK Secretary of State for Health and Social Care launched in 2021 shaping a prevention-first health policy across 20+ countries.
- 30+
- Countries with WHIS activity
- £36:£1
- Independent SROI of community reinvestment
- 20m+
- People engaged worldwide since 2015
- Peer-reviewed
- Oxford UP, Routledge, Emerald & BMJ
Where do you fit in?
WHIS works across sectors. Pick your starting point and we'll show you the most relevant programmes, events, and resources.
Health innovation for organisations
Bring WHIS programmes into your workforce, sector, or city. Strategic advisory, summits, and prevention-first health systems.
Explore →
Communities, families, and life stages
Join the WHIS Health & Wellbeing App pilot, find a chapter near you, and learn how social prescribing can change lives.
Explore →
Policy, investment, and innovation
Co-create with us — partnerships, sponsorship, ventures, and funding opportunities for health innovators worldwide.
Explore →How we deliver impact
Programmes, alliance, convening, and local chapters — how WHIS moves prevention from idea to practice.
- 01 Explore
Programmes
WHISKids, WHISatWork, WHISSeniors, WHISGreen, Hiya, and WHISTech — plus the WHIS Health & Wellbeing App.
- 02 Explore
Global Social Prescribing Alliance (GSPA)
Advancing person-centred, community-based care worldwide through social prescribing.
- 03 Explore
Events & Summits
Global Social Prescribing Alliance (GSPA) Summit, World Health Innovation Day, city summits, webinars, and the Innovators Show.
- 04 Explore
Global chapters
Active in 30+ countries — UK, USA, Italy, India, Ireland, Argentina, Portugal and more.
Featured event
World Health Innovation Summit Venice 2027
The world's leading health investment forum — convening sovereign wealth funds, institutional investors, global policymakers, and clinical leaders at the Venice Lido.
June 2027
World Health Innovation Summit Venice 2027
The world's leading health investment forum — convening sovereign wealth funds, institutional investors, global policymakers, and clinical leaders at the Venice Lido.
Also coming up
- Global Social Prescribing Alliance (GSPA) Special Interest Group
11 December 2026 · 2026 review and 2027 plans · 1–2pm BST Details → - Global Social Prescribing Impact Awards
Nominate changemakers — winners announced at the 2027 Summit. Details → - Social Prescribing Day 2027
27 March 2027 · Worldwide — community-led Details → - Global Social Prescribing Summit 2027
9 July 2027 · Online Details →
Community moments
People, places, and the WHIS network
Summits, chapters, and partnerships worldwide — the faces behind the work.
“An international exchange of ideas, enthusiasm, best practice and shared values, right on our own doorstep.”
Latest news
18 Nov 2026
Welcoming Dr. Mohammad Nami: Expert Advisor to WHIS and the Global Social Prescribing Alliance on Brain Health
Welcoming Dr. Mohammad Nami: Expert Advisor to WHIS and the Global Social Prescribing Alliance on Brain Health We are thrilled to highlight the expertise and vision of Dr. Mohammad Nami, who serves as an Expert Advisor to WHIS and the Global Social Prescribing Alliance on Brain Health. In this role, he will work closely on scaling brain health and its impact on mental health and wellbeing around the world, bringing a wealth of global academic experience, clinical insight, and groundbreaking research in neuroscience to advance these vital initiatives.
-
17 Nov 2026
Closing the Funding and Diagnostic Gap: Why Uniting Capital, Community, and Clinical Action is Essential to Stop AMR
Closing the Funding and Diagnostic Gap: Why Uniting Capital, Community, and Clinical Action is Essential to Stop AMR Antimicrobial Resistance (AMR) is no longer a distant threat—it is a present-day global health and economic crisis. According to the latest assessment released by the World Health Organization (WHO) from the Tracking Antimicrobial Resistance Country Self-assessment Survey (TrACSS), drug-resistant bacterial infections could cause up to 39 million deaths by 2050 without urgent, coordinated intervention. In 2021 alone, bacterial AMR was directly responsible for over 1 million deaths and associated with nearly 4.7 million deaths. As Dr. Jean Pierre Nyemazi, acting director of WHO’s AMR department, highlighted, the clinical pipeline for new treatments is failing to keep pace with rising resistance, rendering routine infections longer to treat, more toxic, and significantly more expensive. At the World Health Innovation Summit (WHIS), we view AMR not only as a clinical challenge, but as a systemic $100 trillion macroeconomic threat to global security, on par with climate change.
-
17 Nov 2026
The World Health Service (WHS) is the not-for-profit arm of World Health Innovation Summit
Help us build the future of healthcare where we leave no-one behind. World Health Service (WHS) | Scaling Prevention-First Healthcare & Community Innovation The World Health Service (WHS) is the not-for-profit arm of World Health Innovation Summit (WHIS) — a financial and governance vehicle that scales proven, community-based healthcare by bridging local innovation with institutional capital.
Watch
The launch of the Global Social Prescribing Alliance
In 2021 the UK Secretary of State for Health and Social Care joined WHIS and its partners to launch the Global Social Prescribing Alliance — a platform for prevention-first, person-centred healthcare worldwide.
Support the future of health & wellbeing
Donate today and be part of the movement shaping the future. Every contribution funds our chapters, programmes, and the WHIS Health & Wellbeing App pilot.